KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Non-Current Debt (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Non-Current Debt for 17 consecutive years, with $42.8 billion as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Debt fell 9.98% to $42.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $42.8 billion, a 9.98% decrease, with the full-year FY2025 number at $42.8 billion, down 9.98% from a year prior.
  • Non-Current Debt was $42.8 billion for Q4 2025 at Bristol Myers Squibb, down from $44.5 billion in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $49.5 billion in Q1 2024 to a low of $32.1 billion in Q3 2023.
  • A 5-year average of $41.2 billion and a median of $41.1 billion in 2021 define the central range for Non-Current Debt.
  • Peak YoY movement for Non-Current Debt: decreased 18.06% in 2021, then surged 51.46% in 2024.
  • Bristol Myers Squibb's Non-Current Debt stood at $39.6 billion in 2021, then fell by 11.49% to $35.1 billion in 2022, then grew by 4.56% to $36.7 billion in 2023, then increased by 29.87% to $47.6 billion in 2024, then dropped by 9.98% to $42.8 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Non-Current Debt are $42.8 billion (Q4 2025), $44.5 billion (Q3 2025), and $44.5 billion (Q2 2025).